Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Comparative Effectiveness Infrastructure Is Priority, Federal Advisors Say

Executive Summary

Both the Institute of Medicine and the Federal Coordinating Council for Comparative Effectiveness Research are placing a high priority on building an infrastructure around comparative effectiveness to facilitate the research as well as the dissemination of findings

You may also be interested in...



PCORI Initiates A Targeted Approach To Research At November Meeting

In a departure from asking researchers to propose specific research topics within broadly defined areas, the board of the Patient-Centered Outcomes Research Institute approved a plan to fund research in three targeted areas – treatment of uterine fibroids, management of asthma in African-Americans and prevention of falls in the elderly – and up to two additional areas.

PCORI Draft Research Agenda Offers Broad Areas Of Study With Intention Of Getting Specifics From Public Comments

The Patient-Centered Outcomes Research Institute’s issues its draft national priorities and research agenda for comment Jan. 23. Rather than identify specific research items, the list contains five broad areas designed to elicit the greatest amount of input from stakeholders on what projects should be funded for investigation.

PCORI Should Consider Health IT In Setting Research Priorities – Board’s Weisman

As the Patient-Centered Outcomes Research Institute begins determining its national priorities and research agenda, one board of governors member, Johnson & Johnson executive Harlan Weisman, is stressing the importance of including health information technology in that process.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS051238

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel